Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Mometasone Nasal Spray vs Nasonex in Seasonal Allergic Rhinitis
NCT01673659Phase 3Completed
- Sponsor
- Padagis
- Start
- Aug 2012
- Primary completion
- Oct 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of mometasone furoate nasal spray in seasonal allergic rhinitis (SAR), sponsored by Padagis. Started Aug 2012; status: completed.
02
Drugs
mometasone furoate nasal spray
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on NCT01673659.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01673659.